0001000229-18-000080.txt : 20180605 0001000229-18-000080.hdr.sgml : 20180605 20180605113802 ACCESSION NUMBER: 0001000229-18-000080 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20180525 FILED AS OF DATE: 20180605 DATE AS OF CHANGE: 20180605 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Daniels Kevin CENTRAL INDEX KEY: 0001740507 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14273 FILM NUMBER: 18880403 MAIL ADDRESS: STREET 1: 6316 WINDFERN ROAD CITY: HOUSTON STATE: TX ZIP: 77040 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CORE LABORATORIES N V CENTRAL INDEX KEY: 0001000229 STANDARD INDUSTRIAL CLASSIFICATION: OIL, GAS FIELD SERVICES, NBC [1389] IRS NUMBER: 000000000 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: STRAWINSKYLAAN 913 STREET 2: TOWER A, LEVEL 9 CITY: 1077 XX AMSTERDAM STATE: P7 ZIP: 1077 XX BUSINESS PHONE: 3124203191 MAIL ADDRESS: STREET 1: 6316 WINDFERN CITY: HOUSTON STATE: TX ZIP: 77040 3 1 wf-form3_152821306575080.xml FORM 3 X0206 3 2018-05-25 0 0001000229 CORE LABORATORIES N V CLB 0001740507 Daniels Kevin 6316 WINDFERN RD HOUSTON TX 77040 0 1 0 0 CAO & Treasurer Restricted Shares Common Shares 2915.0 D Performance Shares Common Shares 2600.0 D Restricted Shares vest in the amount of 1/6th of the grant on each of the six annual anniversaries following the respective grant date. Mr. Daniels has 6 grants still outstanding, and of those the following shares remain unvested at this time: 125 shares from the grant on 9/1/12; 110 shares from the grant on 3/1/13; 140 shares from the grant on 4/1/14; 420 shares from the grant on 7/1/15; 480 shares from the grant on 3/1/16; and 840 shares from the grant on 12/1/17. In addition he has 800 shares from a special grant on 12/1/14 which will vest on 12/1/18. Assuming a recipient's continued employment (or death or disability while employed) and the satisfaction of certain performance goals is achieved, this award would vest at the end of a three-year performance period that began on January 1, 2018 and ends on the last NYSE trading day of December 2020 (the "Performance Period"). At the end of the Performance Period, 100% of the award will vest if the Company is in the top 75th percentile of Return On Invested Capital of the Bloomberg Peer Group as shown by data published by Bloomberg upon the close of the NYSE market on the last trading day of the Performance Period. If this criteria is not met, then no shares shall vest and the award be forfeited. Mark F. Elvig, Attorney-in-Fact 2018-05-25 EX-24 2 poa-carnes.htm POWER OF ATTORNEY - DANIELS Exhibit





1



POWER OF ATTORNEY
Know all by these presents, that the undersigned hereby constitutes and appoints each of Christopher S. Hill, Mark F. Elvig, and Mark Tattoli, or either of them signing singly, and with full power of substitution, the undersigned’s true and lawful attorney‑in‑fact to:
(1)    prepare, execute in the undersigned’s name and on the undersigned’s behalf, and submit to the U.S. Securities and Exchange Commission (the “SEC”) a Form ID, including amendments thereto, and any other documents necessary or appropriate to obtain codes and passwords enabling the undersigned to make electronic filings with the SEC of reports required by Section 16(a) of the Securities Exchange Act of 1934 or any rule or regulation of the SEC;
(2)    execute for and on behalf of the undersigned, in the undersigned’s capacity as an officer and/or director of Core Laboratories N.V. (the “Company”), Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder;
(3)    do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5, complete and execute any amendment or amendments thereto, and timely file such form with the SEC and any stock exchange or similar authority; and
(4)    take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney‑in‑fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney‑in‑fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney‑in‑fact may approve in such attorney‑in‑fact’s discretion.
The undersigned hereby grants to each such attorney‑in‑fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney‑in‑fact, or such attorney‑in‑fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys‑in‑fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.
This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys‑in‑fact.
IN WITNESS WHEREOF, the undersigned have caused this Power of Attorney to be executed as of 10th day of May, 2018.
/s/ Kevin Daniels
Kevin Daniels